Interesse Geral
O que influencia as respostas das pessoas às mensagens de saúde pública para o controle de riscos e prevenção de doenças infecciosas? Uma breve revisão sistemática das evidências e recomendações.
15 Nov, 2021 | 13:57h
Comentário no Twitter
COVID-19 messages should:
1) be developed with communities
2) address uncertainty immediately + with transparency
3) focus on unifying messages from sources
4) frame messages aimed at increasing understanding, social responsibility + ind control https://t.co/faxtAgngAI— Caroline Tomes MFPH (@carotomes) November 12, 2021
Mortes de crianças e jovens na Inglaterra após infecção por SARS-CoV-2 durante o 1º ano da pandemia – “Ao todo, 99,995% das crianças e jovens com teste positivo para SARS-CoV-2 sobreviveram.”
12 Nov, 2021 | 13:48hConteúdo relacionado:
Study: Children and young people remain at low risk of COVID-19 mortality
Comentários no Twitter
Just published @NatureMedicine
An in-depth analysis of the 25 children who died from Covid in England during the 1st year of the pandemichttps://t.co/QK3gk1BXy5
Great that 99.995% of children w/ a positive test survived (not what is driving the need for 💉in kids) pic.twitter.com/moXKl8ysmA— Eric Topol (@EricTopol) November 11, 2021
A clinical review of all pediatric deaths in England from March 2020 to February 2021 attributes 25 deaths to SARS-CoV-2 infection and identifies risk factors to guide interventions, according to a @NatureMedicine article. https://t.co/Bpjhf5sgow pic.twitter.com/v24Zf9CsXK
— Nature Portfolio (@NaturePortfolio) November 11, 2021
Aumento da imunidade às vacinas contra COVID-19 – “Novos estudos destacam os benefícios imunológicos dos reforços da vacina contra COVID-19, mas ainda restam questões sobre como fazer o melhor uso de suprimentos globais limitados.”
12 Nov, 2021 | 13:46hBoosting immunity to COVID-19 vaccines – Nature Medicine
A pandemia de COVID prejudicou a produtividade de pesquisadores – bem como sua saúde mental – “Pesquisas mostram que mulheres, pais de crianças pequenas e pessoas não brancas são as mais afetadas pelas disrupções causadas pela pandemia e precisam de mais apoio.”
12 Nov, 2021 | 13:44hThe COVID pandemic has harmed researcher productivity – and mental health – Nature
Mapa | O mundo segundo a cobertura vacinal contra Covid.
12 Nov, 2021 | 13:43hThe world according to covid vaccine coverage – The BMJ
Comentário no Twitter
A year since the first covid vaccines were announced, rollouts are under way all over the world—to differing degrees.
This map shows the percentage of national population to have received two doses of covid vaccinehttps://t.co/rIU3qeWXIK @munkeatlooi pic.twitter.com/zZHr1XXBe8
— The BMJ (@bmj_latest) November 11, 2021
OMS, CDC | Progresso global contra o sarampo fica ameaçado em meio à pandemia de COVID-19.
12 Nov, 2021 | 13:36hComunicado de imprensa: Global progress against measles threatened amidst COVID-19 pandemic – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
While reported #measles cases have fallen compared to previous years, progress toward measles elimination continues to decline and the risk of outbreaks is mounting, according to a 🆕 report from @CDCgov & WHO.
👉 https://t.co/EjRVRexcGd pic.twitter.com/KnBU5RZn5i
— World Health Organization (WHO) (@WHO) November 10, 2021
Pílulas antivirais contra COVID: o que os cientistas ainda precisam saber – “Medicações como molnupiravir e paxlovid podem mudar o curso da pandemia se os resultados de ensaios clínicos se repetirem no mundo real.”
11 Nov, 2021 | 16:23hCOVID antiviral pills: what scientists still want to know – Nature
Conteúdos relacionados:
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
Merck to allow other nations to produce new COVID-19 antiviral.
Video: Merck’s Covid pill could transform treatment. Here’s how it works.
How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.
What we know — and don’t know — about Merck’s new Covid-19 pill.
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.
Perspectiva | Como será o fim da pandemia: cientistas têm pistas sobre a evolução do SARS-CoV-2.
11 Nov, 2021 | 16:20hCOVID’s endgame: Scientists have a clue about where SARS-CoV-2 is headed – NPR
Novo teste para demência traz mais questões do que respostas – “Uma avaliação de 5 minutos em um iPad poderia transformar o rastreamento da demência – ou sobrecarregar o sistema de saúde com usuários preocupados.”
11 Nov, 2021 | 15:57hA New Dementia Test Raises More Questions Than Answers – Wired
Estudo randomizado | Vacina da Pfizer mostra 90,7% de eficácia na prevenção de Covid-19 em crianças de 5 a 11 anos de idade.
10 Nov, 2021 | 12:55h
Comentário no Twitter
In this multi-phase trial, two 10-μg doses of the BNT162b2 vaccine administered 21 days apart were safe, immunogenic, and 90.7% effective against #COVID19 in 5-to-11-year-old children. #Covid19vaccine https://t.co/kuj2eI4YCE pic.twitter.com/BWEkYxn8a0
— NEJM (@NEJM) November 9, 2021